Pharmacotherapy before and after endovascular intervention in peripheral artery disease
From recommendations to drug administration
Thursday, March 18, 2021
From recommendations to drug administration
Thursday, March 18, 2021
Tomislav Krčmar, M.D., Ph.D.
University Hospital Centre Zagreb
Clinical Hospital Centre Rijeka
Prof. Kristina Selthofer-Relatić, M.D., Ph.D.
University Hospital Centre Osijek
Prof. Mislav Vrsalović, M.D., Ph.D.
Sisters of Mercy University Hospital
Required level of previous knowledge and experience of participants: basic to intermediate
17:00-17:05 | Peripheral artery disease and cardiovascular risk |
Tomislav Krčmar, M.D., Ph.D | |
17:05-17:25 | Drugs that every patient with PAD should have prescribed in therapy |
Prof. Kristina Selthofer-Relatić, M.D., Ph.D. | |
Discussion – questions and answers | |
17:25-17:45 | Antiplatelet therapy of patients before and after endovascular interventions in PAD (review of guidelines and COMPASS study) |
Prof. Mislav Vrsalović, M.D., Ph.D. | |
Discussion - questions and answers | |
17:45-18:05 | Novelties in antiplatelet therapy after the VOYAGER-PAD study |
Tomislav Krčmar, M.D., Ph.D. | |
Discussion - questions and answers | |
18:05-18:15 | Discussion and conclusions |